These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17968839)

  • 1. Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women.
    Lazo M; Gange SJ; Wilson TE; Anastos K; Ostrow DG; Witt MD; Jacobson LP
    Clin Infect Dis; 2007 Nov; 45(10):1377-85. PubMed ID: 17968839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based, multifactorial approach to addressing non-adherence to antiretroviral therapy and improving standards of care.
    Herrmann S; McKinnon E; John M; Hyland N; Martinez OP; Cain A; Turner K; Coombs A; Manolikos C; Mallal S
    Intern Med J; 2008 Jan; 38(1):8-15. PubMed ID: 17916167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus.
    Murphy DA; Belzer M; Durako SJ; Sarr M; Wilson CM; Muenz LR;
    Arch Pediatr Adolesc Med; 2005 Aug; 159(8):764-70. PubMed ID: 16061785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
    Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
    Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.
    Protopopescu C; Raffi F; Roux P; Reynes J; Dellamonica P; Spire B; Leport C; Carrieri MP;
    J Antimicrob Chemother; 2009 Sep; 64(3):599-606. PubMed ID: 19602563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy.
    Golub ET; Benning L; Sharma A; Gandhi M; Cohen MH; Young M; Gange SJ
    Clin Infect Dis; 2008 Jan; 46(2):305-12. PubMed ID: 18171267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-infected pregnant women have greater adherence with antiretroviral drugs than non-pregnant women.
    Vaz MJ; Barros SM; Palacios R; Senise JF; Lunardi L; Amed AM; Castelo A
    Int J STD AIDS; 2007 Jan; 18(1):28-32. PubMed ID: 17326859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How late is too late? Timeliness to scheduled visits as an antiretroviral therapy adherence measure in Nairobi, Kenya and Lusaka, Zambia.
    Blacher RJ; Muiruri P; Njobvu L; Mutsotso W; Potter D; Ong'ech J; Mwai P; Degroot A; Zulu I; Bolu O; Stringer J; Kiarie J; Weidle PJ
    AIDS Care; 2010 Nov; 22(11):1323-31. PubMed ID: 20711886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study.
    Conen A; Fehr J; Glass TR; Furrer H; Weber R; Vernazza P; Hirschel B; Cavassini M; Bernasconi E; Bucher HC; Battegay M;
    Antivir Ther; 2009; 14(3):349-57. PubMed ID: 19474469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV/AIDS, psychiatric and substance-related disorder.
    Applebaum AJ; Richardson MA; Brady SM; Brief DJ; Keane TM
    AIDS Behav; 2009 Feb; 13(1):60-5. PubMed ID: 18690532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
    Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
    Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission.
    Garcia-Tejedor A; Maiques V; Perales A; Lopez-Aldeguer J
    Acta Obstet Gynecol Scand; 2009; 88(8):882-7. PubMed ID: 19557554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in adherence to highly active antiretroviral therapy: a meta-analysis.
    Ortego C; Huedo-Medina TB; Santos P; Rodríguez E; Sevilla L; Warren M; Llorca J
    AIDS Care; 2012; 24(12):1519-34. PubMed ID: 22533692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons.
    Ammassari A; Antinori A; Aloisi MS; Trotta MP; Murri R; Bartoli L; Monforte AD; Wu AW; Starace F
    Psychosomatics; 2004; 45(5):394-402. PubMed ID: 15345784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harmful alcohol consumption and patterns of substance use in HIV-infected patients receiving antiretrovirals (ANRS-EN12-VESPA Study): relevance for clinical management and intervention.
    Michel L; Carrieri MP; Fugon L; Roux P; Aubin HJ; Lert F; Obadia Y; Spire B;
    AIDS Care; 2010 Sep; 22(9):1136-45. PubMed ID: 20824566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of body image dissatisfaction and depression on HAART adherence in HIV positive men: tests of mediation models.
    Blashill AJ; Vander Wal JS
    AIDS Behav; 2010 Apr; 14(2):280-8. PubMed ID: 19888646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to highly active antiretroviral therapy (HAAT) at a Federal Medical Centre.
    Shaahu VN; Lawoyin TO; Sangowawa AO
    Afr J Med Med Sci; 2008 Mar; 37(1):29-36. PubMed ID: 18756852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of anger in adherence to highly active antiretroviral treatment in patients infected with HIV.
    Leombruni P; Fassino S; Lavagnino L; Orofino G; Morosini P; Picardi A
    Psychother Psychosom; 2009; 78(4):254-7. PubMed ID: 19468260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inadequate adherence to antiretroviral treatment and prevention in hospital and community sites in Burkina Faso and Mali: a study by the ATARAO group.
    Aboubacrine SA; Niamba P; Boileau C; Zunzunegui MV; Machouf N; Nguyen VK; Rashed S
    Int J STD AIDS; 2007 Nov; 18(11):741-7. PubMed ID: 18005507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.